brevet
n . 荣誉晋升[令]
荣誉晋升[令]
brevet n 1 :
a document entitling a commissioned officer to hold a higher rank temporarily (
but without higher pay )
v 1 :
promote somebody by brevet ,
in the military Brevet \
Bre *
vet "\ (
br [-
e ]*
v [
e ^]
t ";
277 ),
n . [
F .
brevet ,
LL .
brevetum ,
fr .
L .
brevis short .
See {
Brief }.]
1 .
A warrant from the government ,
granting a privilege ,
title ,
or dignity . [
French usage ].
[
1913 Webster ]
2 . (
Mil .)
A commission giving an officer higher rank than that for which he receives pay ;
an honorary promotion of an officer .
[
1913 Webster ]
Note :
In the United States army ,
rank by brevet is conferred ,
by and with the advice and consent of the Senate ,
for "
gallant actions or meritorious services ."
A brevet rank gives no right of command in the particular corps to which the officer brevetted belongs ,
and can be exercised only by special assignment of the President ,
or on court martial ,
and detachments composed of different corps ,
with pay of the brevet rank when on such duty .
[
1913 Webster ]
Brevet \
Bre *
vet "\ (
br [-
e ]*
v [
e ^]
t "),
v .
t . [
imp . &
p .
p .
{
Brevetted };
p .
pr . &
vb .
n . {
Brevetting }.] (
Mil .)
To confer rank upon by brevet .
[
1913 Webster ]
Brevet \
Bre *
vet "\,
a . (
Mil .)
Taking or conferring rank by brevet ;
as ,
a brevet colonel ;
a brevet commission .
[
1913 Webster ]
82 Moby Thesaurus words for "
brevet ":
agency ,
agentship ,
appointment ,
assignment ,
authority ,
authorization ,
bull ,
care ,
charge ,
charter ,
commission ,
commissioning ,
commitment ,
concession ,
consignment ,
cure ,
declaration ,
decree ,
decree -
law ,
decreement ,
decretal ,
decretum ,
delegated authority ,
delegation ,
deputation ,
devolution ,
devolvement ,
dictum ,
diktat ,
diploma ,
edict ,
edictum ,
embassy ,
empowerment ,
entrusting ,
entrustment ,
errand ,
executorship ,
exequatur ,
factorship ,
fiat ,
franchise ,
full power ,
grant ,
ipse dixit ,
jurisdiction ,
law ,
legation ,
letters patent ,
liberty ,
license ,
lieutenancy ,
mandate ,
mission ,
office ,
ordinance ,
ordonnance ,
patent ,
plenipotentiary power ,
power of attorney ,
power to act ,
proclamation ,
procuration ,
pronouncement ,
pronunciamento ,
proxy ,
purview ,
regency ,
regentship ,
rescript ,
responsibility ,
royal grant ,
rule ,
ruling ,
senatus consult ,
senatus consultum ,
task ,
trust ,
trusteeship ,
ukase ,
vicarious authority ,
warrant
安装中文字典英文字典查询工具!
中文字典英文字典工具:
复制到剪贴板
英文字典中文字典相关资料:
尼达尼布(Nintedanib):多靶点酪氨酸激酶抑制剂的临床 . . . 尼达尼布 (Nintedanib)是一种口服多靶点酪氨酸激酶抑制剂,能够同时抑制多种受体酪氨酸激酶(RTKs),包括血小板衍生生长因子受体(PDGFR)、成纤维细胞生长因子受体(FGFR)、血管内皮生长因子受体(VEGFR)等。
尼达尼布_百度百科 尼达尼布(Nintedanib),商品名维加特(Ofev),化学名称1H-吲哚-6-羧酸,2,3-二氢-3- [ [ [4- [甲基 [ (4-甲基-1-哌嗪基)乙酰基]氨基]苯基]氨基]苯基亚甲基]-2-氧-,甲酯, (3Z)-,是由德国勃林格殷格翰公司研发的小分子酪氨酸激酶抑制剂。
Nintedanib - Wikipedia Nintedanib, sold under the brand names Ofev and Vargatef, is an oral medication used for the treatment of idiopathic pulmonary fibrosis and along with other medications for some types of non-small-cell lung cancer
尼達尼布 - 维基百科,自由的百科全书 尼達尼布 (英語: Nintedanib)為一種新一代治療癌病及特發性肺纖維化的口服藥物,是一種三重血管激酶抑制劑,可同時針對抑制三個導致血管更生與腫瘤增長的主要受體,包括血管內皮生長因子受體 (VEGFR)、血小板源性生長因子受體 (PDGFR)與纖維母細胞
Nintedanib (BIBF 1120,尼达尼布) - 仅供科研 | PDGFR . . . Nintedanib (BIBF 1120) 是一种有效的三重血管激酶抑制剂,抑制 VEGFR1 2 3,FGFR1 2 3 和 PDGFRα β 的 IC50 值分别为 34 nM 13 nM 13 nM,69 nM 37 nM 108 nM 和 59 nM 65 nM。 - 高纯度,全球文献引用。
Nintedanib: Uses, Dosage, Side Effects, Warnings - Drugs. com Nintedanib information from Drugs com, includes Nintedanib side effects, dosage, interactions, indications, how to take, and use in pregnancy and breastfeeding
尼达尼布(Nintedanib)适用于特发性肺纤维化(IPF) 尼达尼布(Nintedanib)是一种口服小分子多靶点酪氨酸激酶抑制剂,主要用于治疗特发性肺纤维化(IPF)、系统性硬化病相关间质性肺疾病(SSc-ILD)等纤维化性肺病。 中重度或慢性患者:通常需长期服用以…
乙磺酸尼达尼布(Nintedanib esylate) - 药物靶点:CSF-1R x . . . It aims to evaluate the efficacy and safety of tislelizumab combined with nintedanib as consolidation therapy for patients with limited-stage small cell lung cancer after concurrent chemoradiotherapy, and to explore the prognostic markers related to the therapeutic effect
尼达尼布(Nintedanib)适应症 - 知乎 尼达尼布(Nintedanib)是一种多靶点酪氨酸激酶抑制剂,主要用于治疗多种肺纤维化疾病及特定类型的非小细胞肺癌。 以下是其主要的适应症及作用机制: 1 特发性肺纤维化(IPF) 尼达尼布通过抑制血管内皮生长因…
Nintedanib(尼达尼布)的中文说明书_患者_风险_治疗 英文名:Nintedanib 🧬 成分 主要成分:Nintedanib(尼达尼布) 化学名称:6-甲氧基-2- [4- (N-甲基-2-吡啶基氨基)苯氧基]-3-氰基-4- (3-吡啶羧酰胺基)喹啉 分子式:C₃₁H₃₃N₅O₄ 分子量:539 63 💡 性状 本品为胶囊剂,内容物为浅黄色至棕黄色粉末或颗粒